Do Wall Street Analysts Like HCA Healthcare Stock?

HCA Healthcare, a massive U.S. healthcare services company, has a market capitalization of $88 billion and operates a wide range of healthcare facilities. Despite its size, the company's stock has underperformed the broader market, with the S&P 500 gaining 19.5% over the past 52 weeks while HCA shares have only risen marginally.

The company delivered solid Q2 2026 results, with revenue up 8.7% year-over-year and adjusted EPS increasing 11%, but it still trimmed its full-year outlook. Analysts see mixed earnings surprises from HCA, with a consensus rating of Moderate Buy based on 13 Strong Buy ratings, one Moderate Buy, 10 Holds, and one Strong Sell. JPMorgan recently lowered its price target to $425 from $490, suggesting a more cautious view of HCA's upside potential.